ライフサイエンスコーパス: interleukin-11

1 tokines (e.g. leukemia inhibitory factor and interleukin 11).

2 rleukin 6 was about 10-fold more potent that interleukin 11.

3 inhibitory factor [LIF], oncostatin M [OSM], interleukin-11 and cardiotrophin-1) also potentiated the

4 Interleukin-11 and inhibitor of DNA-binding domain-1 gen

5 thesis also by using in vitro expansion with interleukin-11 and steel factor of lineage(-) c-kit(+) S

6 em cells that were activated in culture with interleukin-11 and steel factor were also CD38(-).

7 ) individually for 1 week in the presence of interleukin-11 and steel factor.

8 and function of CD4(+) T cells by secreting interleukin 11, and neutralization of IL11 abrogates MSC

9 nhibitors include somatostatin, nefstatin-1, interleukin-11, and calcitonin gene-related peptide.

10 dies show the potential of recombinant human interleukin-11 as a treatment for chemotherapy-induced t

11 ry responses; furthermore, interleukin 6 and interleukin 11 can abrogate T-cell activation due to tri

12 ciliary neurotrophic factor, interleukin-6, interleukin-11, cardiotrophin-1, and leukemia inhibitory

13 Interleukin-11 concentrations were highest within gingiv

14 expression in primary breast tumours and low interleukin-11 correlates with relapse-free survival in

15 on of microRNA-30c inversely correlates with interleukin-11 expression in primary breast tumours and

16 th factor 18), CTSK (cathepsin K), and IL11 (interleukin 11), have therapeutics approved or in clinic

17 ystems to investigate the contributions that interleukin 11 (IL-11) and IL-13 might make to airway re

18 Earlier we demonstrated that blocking of interleukin 11 (IL-11) by systemic administration of ant

19 t, we selected and isolated a mimic motif of interleukin 11 (IL-11) from prostate biopsies after an i

20 Here we investigated the role of Interleukin 11 (IL-11) in a mouse model of injury-relate

21 system and used this system to express human interleukin 11 (IL-11) in respiratory structures.

22 dulators of IFN response-betacellulin (BTC), interleukin 11 (IL-11), and IL-17F-that caused time-depe

23 ivalently, on days 1 and 15, with or without interleukin 11 (IL-11; 15 microg/kg per day on days 3 to

24 M (OSM), Ciliary Neurotrophic Factor (CNTF), Interleukin-11 (IL-11) and Cardiotrophin (CT-1).

25 ulating repair in MS lesions, and identified interleukin-11 (IL-11) as an astrocyte-derived factor th

26 The mechanisms of interleukin-11 (IL-11) cytoprotection in intestinal epit

27 Interleukin-11 (IL-11) is a growth factor that increases

28 Interleukin-11 (IL-11) is a profibrotic cytokine essenti

29 Interleukin-11 (IL-11) is a thrombopoietic cytokine that

30 Interleukin-11 (IL-11) is a unique thrombopoietic growth

31 mary human fibroblasts, that upregulation of interleukin-11 (IL-11) is the dominant transcriptional r

32 l line, resulted in a prolonged elevation of interleukin-11 (IL-11) mRNA, which can be inhibited by p

33 ASCL2 target genes include the interleukin-11 (IL-11) receptor Il11ra1, and recombinant

34 The multifunctional cytokine, interleukin-11 (IL-11), ameliorates the intestinal radia

35 First, we showed that the expression of interleukin-11 (IL-11), an anti-inflammatory cytokine ma

36 n of another member of this cytokine family, interleukin-11 (IL-11), and components of its receptor (

37 easured the levels of thrombo-poietin (TPO), interleukin-11 (IL-11), and interleukin-6 (IL-6) in pati

38 However, in combination with interleukin-11 (IL-11), both FL and KL enhanced the prod

39 ukin-1beta (IL-1beta), interleukin-6 (IL-6), interleukin-11 (IL-11), oncostatin M (OSM), and leukemia

40 The role of Interleukin 11 (IL11) in heart regeneration remains cont

41 e model of APAP-induced liver injury (AILI), interleukin 11 (IL11) is highly up-regulated and adminis

42 Interleukin 11 (IL11) is important for pulmonary fibrobl

43 We studied the role of interleukin 11 (IL11) signaling in the pathogenesis of n

44 evealed large and consistent upregulation of Interleukin 11 (IL11).

45 itial lung disease and found the profibrotic Interleukin-11 (IL11) cytokine to be highly and specific

46 lopram was best predicted by a marker in the interleukin-11 (IL11) gene.

47 eosomes at enhancers in the fibrogenic genes interleukin-11 (IL11), platelet-derived growth factor-B

48 czki and colleagues report the importance of interleukin 11 in a variety of gastrointestinal malignan

49 ony-stimulating factor (GM-CSF) in 1991, and interleukin-11 in 1997.

50 to investigate the use of recombinant human interleukin-11 in patients with chemotherapy-induced thr

51 Because RANKL- and interleukin-11-induced OCL formation was also reduced in

52 Interleukin-11 is a pleotropic cytokine produced by lung

53 An interleukin-6 family member, interleukin-11 is identified as a secondary target of tw

54 Interleukin 6 and interleukin 11, known to activate STAT3 synergistically,

55 in 3, KN motif and ankyrin repeat domains 4, interleukin 11, NADPH oxidase 4, and BTB [POZ] domain co

56 mulating factor (G-CSF), erythropoietin, and interleukin-11 or G-CSF alone to mobilize stem cells.

57 Mice with disruption of the interleukin 11 receptor subunit alpha1 gene (Il11ra1(-/-

58 The interleukin-11 receptor alpha (IL-11Ralpha) is a functio

59 -11 (IL-11), and components of its receptor (interleukin-11 receptor; IL-11R), ie, IL-11Ralpha (invol

60 Recombinant human interleukin 11 (rhIL-11) is a cytokine with thrombocytop

61 Recombinant human interleukin-11 (rhIL-11) has recently become available c

62 rformed a phase I trial of recombinant human interleukin-11 (rhIL-11) in women with breast cancer.

63 Recombinant human interleukin-11 (rhIL-11) is a multifunctional cytokine t

64 e therapeutic potential of recombinant human interleukin-11 (rhIL-11) was tested in a neutropenic rat

65 Recombinant human interleukin-11 (rhIL-11), a glycoprotein 130 (gp130)-sig

66 gation was to determine if recombinant human interleukin-11 (rhIL-11), known to downregulate several

67 e thrombopoietic cytokine, recombinant human interleukin-11 (rhIL-11), on megakaryocytopoiesis in vit

68 hematopoietic activity of recombinant human interleukin-11 (rhIL-11, [Neumega, Cambridge, MA]) in pa

69 the efficacy and safety of recombinant human interleukin-11 (rhIL-11; Neumega, Genetics Institute, In

70 binant epiregulin, amphiregulin, CX3CL1, and interleukin-11 significantly enhanced ureteric bud branc

71 Recombinant human interleukin-11 stimulates megakaryocytopoiesis in vitro

72 The other activities of recombinant human interleukin-11, such as its ability to ameliorate mucosi

73 In VSMCs, TGFbeta induces IL (interleukin) 11) that stimulates ERK-dependent secretion

74 poietic growth factors (, thrombopoietin and interleukin-11) to prevent or treat neonatal thrombocyto

75 the role of two cytokines, interleukin 6 and interleukin 11, which share the signal transducing subun